• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超过 30% 的边缘带脾淋巴瘤患者表达相同的免疫球蛋白重链可变基因:个体发生学意义。

Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.

机构信息

Democritus University of Thrace, Alexandroupolis, Greece.

出版信息

Leukemia. 2012 Jul;26(7):1638-46. doi: 10.1038/leu.2012.3. Epub 2012 Jan 6.

DOI:10.1038/leu.2012.3
PMID:22222599
Abstract

We performed an immunogenetic analysis of 345 IGHV-IGHD-IGHJ rearrangements from 337 cases with primary splenic small B-cell lymphomas of marginal-zone origin. Three immunoglobulin (IG) heavy variable (IGHV) genes accounted for 45.8% of the cases (IGHV1-2, 24.9%; IGHV4-34, 12.8%; IGHV3-23, 8.1%). Particularly for the IGHV1-2 gene, strong biases were evident regarding utilization of different alleles, with 79/86 rearrangements (92%) using allele ()04. Among cases more stringently classified as splenic marginal-zone lymphoma (SMZL) thanks to the availability of splenic histopathological specimens, the frequency of IGHV1-2()04 peaked at 31%. The IGHV1-2()04 rearrangements carried significantly longer complementarity-determining region-3 (CDR3) than all other cases and showed biased IGHD gene usage, leading to CDR3s with common motifs. The great majority of analyzed rearrangements (299/345, 86.7%) carried IGHV genes with some impact of somatic hypermutation, from minimal to pronounced. Noticeably, 75/79 (95%) IGHV1-2()04 rearrangements were mutated; however, they mostly (56/75 cases; 74.6%) carried few mutations (97-99.9% germline identity) of conservative nature and restricted distribution. These distinctive features of the IG receptors indicate selection by (super)antigenic element(s) in the pathogenesis of SMZL. Furthermore, they raise the possibility that certain SMZL subtypes could derive from progenitor populations adapted to particular antigenic challenges through selection of VH domain specificities, in particular the IGHV1-2(*)04 allele.

摘要

我们对 337 例原发性脾脏边缘区小 B 细胞淋巴瘤的 345 个 IGHV-IGHD-IGHJ 重排进行了免疫遗传学分析。3 种免疫球蛋白(IG)重链可变(IGHV)基因占 45.8%(IGHV1-2,24.9%;IGHV4-34,12.8%;IGHV3-23,8.1%)。特别是 IGHV1-2 基因,在不同等位基因的利用上存在明显的偏向,79/86 个重排(92%)使用等位基因 ()04。在由于获得脾脏组织病理学标本而被更严格归类为脾脏边缘区淋巴瘤(SMZL)的病例中,IGHV1-2()04 的频率高达 31%。IGHV1-2()04 重排的互补决定区 3(CDR3)明显长于所有其他病例,并显示出偏向的 IGHD 基因利用,导致具有共同基序的 CDR3。分析的绝大多数重排(299/345,86.7%)携带具有一定体细胞超突变影响的 IGHV 基因,从最小到显著。值得注意的是,75/79(95%)IGHV1-2()04 重排发生突变;然而,它们大多数(75 例中有 56 例;74.6%)携带少数(97-99.9% 种系同一性)保守性质和受限分布的突变。这些 IG 受体的独特特征表明,在 SMZL 的发病机制中,存在(超)抗原成分的选择。此外,它们提出了这样一种可能性,即某些 SMZL 亚型可能源自通过选择 VH 结构域特异性,特别是 IGHV1-2(*)04 等位基因,适应特定抗原挑战的祖细胞群体。

相似文献

1
Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.超过 30% 的边缘带脾淋巴瘤患者表达相同的免疫球蛋白重链可变基因:个体发生学意义。
Leukemia. 2012 Jul;26(7):1638-46. doi: 10.1038/leu.2012.3. Epub 2012 Jan 6.
2
An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors.表达 IGHV1-2*04 受体的脾边缘区淋巴瘤中持续抗原相互作用的免疫遗传特征。
Clin Cancer Res. 2016 Apr 15;22(8):2032-40. doi: 10.1158/1078-0432.CCR-15-1170. Epub 2015 Dec 8.
3
Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires.脾边缘区淋巴瘤:免疫球蛋白重链基因库的临床聚类
Blood Cells Mol Dis. 2009 May-Jun;42(3):286-91. doi: 10.1016/j.bcmd.2009.01.004. Epub 2009 Feb 27.
4
IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas.IGHV 基因特征和 MYD88 L265P 突变将三种边缘区淋巴瘤实体和华氏巨球蛋白血症/淋巴浆细胞淋巴瘤区分开来。
Leukemia. 2013 Jan;27(1):183-9. doi: 10.1038/leu.2012.257. Epub 2012 Sep 4.
5
Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype.弥漫性大 B 细胞淋巴瘤免疫球蛋白基因重排的分子特征:抗原驱动起源和 IGHV4-34 作为非生发中心 B 细胞亚型的一个特定亚群。
Am J Pathol. 2012 Nov;181(5):1879-88. doi: 10.1016/j.ajpath.2012.07.028. Epub 2012 Sep 11.
6
Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphoma.脾边缘区淋巴瘤中的免疫球蛋白重链和轻链库
Mol Med. 2004 Jul-Dec;10(7-12):89-95. doi: 10.2119/2005-00001.Stamatopoulos.
7
Splenic marginal-zone lymphoma: one or more entities? A histologic, immunohistochemical, and molecular study of 42 cases.脾边缘区淋巴瘤:是一种还是多种实体?42例病例的组织学、免疫组化及分子研究
Am J Surg Pathol. 2007 Mar;31(3):438-46. doi: 10.1097/01.pas.0000213419.08009.b0.
8
Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.具有定型B细胞受体的慢性淋巴细胞白血病的分子和临床特征:一项意大利多中心研究的结果
Br J Haematol. 2009 Feb;144(4):492-506. doi: 10.1111/j.1365-2141.2008.07469.x. Epub 2008 Nov 19.
9
Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.塞尔维亚慢性淋巴细胞白血病患者中 IGHV-IGHD-IGHJ 重排的突变状态和基因库。
Clin Lymphoma Myeloma Leuk. 2012 Aug;12(4):252-60. doi: 10.1016/j.clml.2012.03.005. Epub 2012 May 4.
10
Pattern and distribution of immunoglobulin VH gene usage in a cohort of B-CLL patients from a Northeastern region of Italy.意大利东北部一组B细胞慢性淋巴细胞白血病患者免疫球蛋白VH基因使用模式及分布情况
Diagn Mol Pathol. 2006 Dec;15(4):206-15. doi: 10.1097/01.pdm.0000213469.85301.d6.

引用本文的文献

1
Antigen selection reflected in the subclonal architecture of the B-cell receptor immunoglobulin gene repertoire in splenic marginal zone lymphoma.抗原选择反映在脾边缘区淋巴瘤B细胞受体免疫球蛋白基因库的亚克隆结构中。
Hemasphere. 2025 May 27;9(5):e70147. doi: 10.1002/hem3.70147. eCollection 2025 May.
2
Loss of CYLD promotes splenic marginal zone lymphoma.CYLD缺失促进脾边缘区淋巴瘤。
Hemasphere. 2025 Mar 17;9(3):e70098. doi: 10.1002/hem3.70098. eCollection 2025 Mar.
3
Stereotyped B-Cell Receptor Immunoglobulins in B-Cell Lymphomas.
B 细胞淋巴瘤中定型的 B 细胞受体免疫球蛋白。
Methods Mol Biol. 2025;2865:125-143. doi: 10.1007/978-1-0716-4188-0_6.
4
The genomic and molecular landscape of splenic marginal zone lymphoma, biological and clinical implications.脾边缘区淋巴瘤的基因组和分子图谱、生物学及临床意义
Explor Target Antitumor Ther. 2024;5(4):877-901. doi: 10.37349/etat.2024.00253. Epub 2024 Jul 23.
5
Krüppel-like factor 2: a central regulator of B cell differentiation and plasma cell homing.Krüppel 样因子 2:B 细胞分化和浆细胞归巢的中央调节因子。
Front Immunol. 2023 May 12;14:1172641. doi: 10.3389/fimmu.2023.1172641. eCollection 2023.
6
Landscape of immunoglobulin heavy chain gene repertoire and its clinical relevance to LPL/WM.免疫球蛋白重链基因库的特征及其与 LPL/WM 的临床相关性。
Blood Adv. 2022 Jul 12;6(13):4049-4059. doi: 10.1182/bloodadvances.2022007279.
7
New Insights into the Biology and Diagnosis of Splenic Marginal Zone Lymphomas.脾脏边缘区淋巴瘤的生物学和诊断的新见解。
Curr Oncol. 2021 Sep 6;28(5):3430-3447. doi: 10.3390/curroncol28050297.
8
Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters.吸入型强效 SARS-CoV-2 中和人源单克隆抗体在仓鼠中的治疗活性。
Cell Rep Med. 2021 Mar 16;2(3):100218. doi: 10.1016/j.xcrm.2021.100218. Epub 2021 Feb 25.
9
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL.刻板亚群之间的高阶连接:对 CLL 中改善患者分类的影响。
Blood. 2021 Mar 11;137(10):1365-1376. doi: 10.1182/blood.2020007039.
10
Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion and ME/CFS.血浆蛋白质组谱分析提示抗原驱动的克隆 B 细胞扩增与 ME/CFS 之间存在关联。
PLoS One. 2020 Jul 21;15(7):e0236148. doi: 10.1371/journal.pone.0236148. eCollection 2020.